We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Temperature Affects Leukocyte Surface Antigen Expression

By LabMedica International staff writers
Posted on 14 Apr 2011
Flow cytometry analysis of leukocyte surface antigens has been used to characterize infectious and septic processes in patients.

Factors that affect leukocyte immunophenotyping include sampling and processing temperature, the anticoagulant used, and the storage temperature of the blood sample.

Scientists at the University of Oulu, (Oulu, Finland), investigated the possible effects of anticoagulant, sample collection, storage and processing temperature, and sample storage time, on the expression of several leukocyte surface antigens. They collected blood from five male patients, aged 44-68, with severe sepsis requiring intensive care and five healthy staff members (two males and three females, aged 22-62). In this study, the patients and the healthy volunteers were combined into one study population.

Blood was collected into siliconized vacuum tubes containing acid citrate dextrose (ACD) or sodium heparin as an anticoagulant and stored either at 4 °C or at room temperature (RT). Aliquots of the blood samples were incubated with various antibodies at different temperatures and times and analyzed on a FACSCalibur flow cytometer (BD Bioscience; San Jose, CA, USA). The surface antigens of interest were neutrophilic cluster of differentiation (CD)11b and CD64, monocytic CD11b, CD14, CD40, CD64, CD80 and human leukocyte antigen, HLA-DR, and lymphocytic CD69 (separately in CD4+ and CD8+ T cells, B cells, and natural killer cells).

The fluorescence intensities were higher at RT than at 4 °C. During storage the intensities increased at RT, but at 4 °C there were only minor changes. The effects were similar with both anticoagulants studied. The authors concluded that the study shows in a quantitative way that storing the blood samples at RT may have pronounced effects on the intensities of several leukocyte surface antigens, something which is of interest in leukocyte activation studies, such as patients with sepsis. They recommended that flow cytometric analysis of leukocyte surface antigen expressions should be performed using 4 °C temperature throughout the process and within six hours. The study was published online March 15, 2011, in the Journal of Clinical Laboratory Analysis.

Related Links:
University of Oulu
BD Bioscience



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centromere B Assay
Centromere B Test
New
Malaria Test
STANDARD Q Malaria P.f/Pan Ag
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The study validated the Lumipulse p-tau21 automated and scalable blood test system (Photo courtesy of Fujirebio)

Blood Test for Early Alzheimer's Detection Achieves Over 90% Accuracy

Alzheimer's disease (AD) is a debilitating condition and a leading cause of disability and death worldwide. The availability of reliable diagnostic tools is currently restricted, and diagnosis often relies... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.